Published in Cytogenet Genome Res on January 01, 2007
Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced translocations in cancer. Proc Natl Acad Sci U S A (2008) 1.16
Global genomic characterization of acute lymphoblastic leukemia. Semin Hematol (2009) 1.02
Gene-expression profiles in hereditary breast cancer. N Engl J Med (2001) 29.80
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet (2003) 18.67
A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet (1997) 12.94
Complete genome sequence and comparative analysis of the metabolically versatile Pseudomonas putida KT2440. Environ Microbiol (2002) 8.11
Substantial genetic influence on cognitive abilities in twins 80 or more years old. Science (1997) 5.76
Percutaneous pyelolithotomy. A new extraction technique. Scand J Urol Nephrol (1976) 5.01
TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains. Genes Chromosomes Cancer (1995) 4.59
Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid. Lancet (1991) 4.33
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer (2008) 3.87
Control of resistance, exchange, and capacitance functions in the peripheral circulation. Pharmacol Rev (1968) 3.19
[Spinal manipulation is only a part of total care]. Lakartidningen (1992) 3.17
Dual function of the selenoprotein PHGPx during sperm maturation. Science (1999) 2.93
Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci U S A (1990) 2.87
Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies. Int J Cancer (1974) 2.80
Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. Proc Natl Acad Sci U S A (2000) 2.61
Heritability for Alzheimer's disease: the study of dementia in Swedish twins. J Gerontol A Biol Sci Med Sci (1997) 2.59
DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum Mol Genet (2001) 2.50
High-resolution genome-wide array-based comparative genome hybridization reveals cryptic chromosome changes in AML and MDS cases with trisomy 8 as the sole cytogenetic aberration. Leukemia (2006) 2.45
Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin Cancer Res (2000) 2.43
High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients. Cancer Res (1996) 2.43
Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev (2000) 2.37
Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer. Am J Hum Genet (1997) 2.33
Abolished tubuloglomerular feedback and increased plasma renin in adenosine A1 receptor-deficient mice. Am J Physiol Regul Integr Comp Physiol (2001) 2.29
HIV in pregnant women and their offspring: evidence for late transmission. Lancet (1991) 2.27
Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden. J Clin Oncol (1998) 2.24
Onset of terminal decline in cognitive abilities in individuals without dementia. Neurology (2008) 2.24
Indicators of prognosis in node-negative breast cancer. N Engl J Med (1990) 2.23
Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families. Hum Mol Genet (2001) 2.19
Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Res (1997) 2.14
Evidence that the amyloid fibril protein in senile systemic amyloidosis is derived from normal prealbumin. Biochem Biophys Res Commun (1988) 2.13
Changes in CD8 and CD4 lymphocyte subsets, T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study. Mech Ageing Dev (1998) 2.12
Epstein-Barr virus-associated complement-fixing and nuclear antigens in Burkitt lymphoma biopsies. Int J Cancer (1974) 2.10
Surface immunoglobulin-moieties on lymphoid cells. Exp Cell Res (1970) 2.09
Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes. Cancer (1998) 2.06
Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res (1997) 2.03
Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol (1996) 2.03
Encephalitis in immunocompetent patients due to herpes simplex virus type 1 or 2 as determined by type-specific polymerase chain reaction and antibody assays of cerebrospinal fluid. J Med Virol (1993) 2.01
Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer. Am J Pathol (2000) 2.01
Rearrangement of the transcription factor gene CHOP in myxoid liposarcomas with t(12;16)(q13;p11). Genes Chromosomes Cancer (1992) 1.99
Full-length sequence of an ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C. AIDS Res Hum Retroviruses (1996) 1.92
Specific binding of proinsulin C-peptide to human cell membranes. Proc Natl Acad Sci U S A (1999) 1.91
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet (2005) 1.91
Molybdenum at high pressure and temperature: melting from another solid phase. Phys Rev Lett (2008) 1.89
Whole-arm t(1;16) and i(1q) as sole anomalies identify gain of 1q as a primary chromosomal abnormality in breast cancer. Genes Chromosomes Cancer (1992) 1.86
A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions. Cancer Res (2000) 1.86
Midlife overweight and obesity increase late-life dementia risk: a population-based twin study. Neurology (2011) 1.84
Tumour biological features of BRCA1-induced breast and ovarian cancer. Eur J Cancer (1997) 1.82
Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer. Genes Chromosomes Cancer (1999) 1.82
An estrogen receptor mutant with strong hormone-independent activity from a metastatic breast cancer. Cancer Res (1997) 1.82
Cell surface localized IgM-kappa immunoglobulin reactivity in a case of chronic lymphocytic leukaemia. Clin Exp Immunol (1970) 1.80
Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and nonsurvivors. J Gerontol A Biol Sci Med Sci (1995) 1.78
Genomic profiling of malignant melanoma using tiling-resolution arrayCGH. Oncogene (2007) 1.72
Classification of BRCA1 missense variants of unknown clinical significance. J Med Genet (2005) 1.71
A clinical and genetic study of the Say/Barber/Biesecker/Young-Simpson type of Ohdo syndrome. Clin Genet (2008) 1.71
Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res (1994) 1.70
Effects of arterial carbon dioxide tension and oxygen saturation on cerebral blood flow autoregulation in dogs. Acta Physiol Scand Suppl (1965) 1.70
Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden. Am J Hum Genet (1996) 1.69
Ten novel 11q23 chromosomal partner sites. European 11q23 Workshop participants. Leukemia (1998) 1.67
Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus. Proc Natl Acad Sci U S A (2000) 1.66
Isochromosomes in neoplasia. Genes Chromosomes Cancer (1994) 1.64
Insights into the genomic basis of niche specificity of Pseudomonas putida KT2440. Environ Microbiol (2004) 1.61
Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. Am J Hum Genet (1998) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
A novel and cytogenetically cryptic t(7;21)(p22;q22) in acute myeloid leukemia results in fusion of RUNX1 with the ubiquitin-specific protease gene USP42. Leukemia (2006) 1.60
Impaired phytohaemagglutinin-induced cytotoxicity in vitro of lymphocytes from patients with Hodgkin's disease or chronic lymphatic leukaemia. Clin Exp Immunol (1967) 1.57
Epstein-Barr virus (EBV)-associated antibody patterns in malignant lymphoma and leukemia. I. Hodgkin's disease. Int J Cancer (1970) 1.57
Sympathetic control of rhythmically active vascular smooth muscle as studied by a nerve-muscle preparation of portal vein. Acta Physiol Scand (1968) 1.56
Prospective randomized multicentre study of laparoscopic versus open appendicectomy. Br J Surg (1999) 1.52
Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations. Genomics (1999) 1.52
Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status. Leukemia (2007) 1.52
Evidence of phosphorylated phosphatidylinositols in the growth cycle of suspension cultured plant cells. Biochem Biophys Res Commun (1986) 1.52
Pre-compiling medical logic modules into C++ in building medical decision support systems. Comput Methods Programs Biomed (1993) 1.49
A somatic BRCA2 mutation in RER+ endometrial carcinomas that specifically deletes the amino-terminal transactivation domain. Genes Chromosomes Cancer (1999) 1.49
Senile cardiac amyloidosis: evidence of two different amyloid substances in the ageing heart. Scand J Immunol (1979) 1.48
Karyotypic characterization of colorectal adenocarcinomas. Genes Chromosomes Cancer (1995) 1.48
Modifications of human and viral deoxyribonucleic acid by formaldehyde fixation. Lab Invest (1994) 1.48
The incidence of complications in endoscopic anterior thoracolumbar spinal reconstructive surgery. A prospective multicenter study comprising the first 100 consecutive cases. Spine (Phila Pa 1976) (1995) 1.48
Melanoma and nonmelanoma skin cancer in patients with multiple tumours--evidence for new syndromes in a population-based study. Br J Dermatol (2004) 1.46
Clinical significance of cytogenetic findings in solid tumors. Cancer Genet Cytogenet (1997) 1.46
Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis. Int J Gynecol Pathol (1998) 1.44
Typing of human papillomavirus by pyrosequencing. Lab Invest (2001) 1.44
Deletion of 1p loci and microsatellite instability in colorectal polyps. Genes Chromosomes Cancer (1995) 1.43
Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer. Am J Pathol (1999) 1.42
The effect of hyperosmolarity on intacet and isolated vascular smooth muscle. Possible role in exercise hyperemia. Angiologica (1967) 1.42
Contractile properties of two varieties of twitch muscle fibres in Xenopus laevis. Acta Physiol Scand (1982) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Trisomy 7 in short-term cultures of colorectal adenocarcinomas. Genes Chromosomes Cancer (1991) 1.41
Molecular dynamics study of melting and fcc-bcc transitions in Xe. Phys Rev Lett (2001) 1.41
Plasma cytokine profiles in elderly humans. Mech Ageing Dev (2003) 1.40
Identification of novel candidate genes associated with cleft lip and palate using array comparative genomic hybridisation. J Med Genet (2007) 1.40
Karyotypic comparisons of multiple tumorous and macroscopically normal surrounding tissue samples from patients with breast cancer. Cancer Res (1996) 1.40
Adenosine-dopamine interactions in the brain. Neuroscience (1992) 1.39
New chromosomal rearrangement, t(12;22)(p13;q12), in acute nonlymphocytic leukemia. Cancer Genet Cytogenet (1991) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Successful treatment of a patient with chronic lymphocytic leukaemia (CLL) presenting with bony metastases with aggressive antibody and chemotherapy. Clin Lab Haematol (2005) 1.39